Results 21 to 30 of about 1,333 (181)

CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm

open access: yesCase Reports in Critical Care, 2021
Accumulating evidence suggests that a patient subgroup with severe COVID-19 develops a cytokine release syndrome leading to capillary leakage and organ injury.
Alice-Christin Acevedo   +5 more
doaj   +2 more sources

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

open access: yesCritical Care, 2023
Objectives The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically ill COVID-19 ...
J. W. Awori Hayanga   +8 more
doaj   +2 more sources

Hemoadsorption

open access: yesClinical Journal of the American Society of Nephrology
...
Bellomo R.   +35 more
openaire   +5 more sources

Hemoadsorption in Patients with Various Types of Respiratory Support for Severe COVID-19

open access: yesОбщая реаниматология, 2022
Study aim. To evaluate the efficacy of hemoadsorption in patients with severe COVID-19 on mechanical lung ventilation (MLV) and noninvasive respiratory support.Material and methods.
R. E. Yakubtsevich, D. N. Rakashevich
doaj   +3 more sources

Hemoadsorption Therapy for Critically Ill Patients with Acute Liver Dysfunction: A Meta-Analysis and Systematic Review

open access: yesBiomedicines, 2023
Critically ill patients are at risk of developing acute liver dysfunction as part of multiorgan failure sequelae. Clearing the blood from toxic liver-related metabolites and cytokines could prevent further organ damage.
Caner Turan   +8 more
doaj   +2 more sources

Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function

open access: yesIntensive Care Medicine Experimental, 2017
Background Mounting evidence suggests that sepsis-induced morbidity and mortality are due to both immune activation and immunosuppression. Resistin is an inflammatory cytokine and uremic toxin.
Anthony Bonavia   +3 more
doaj   +2 more sources

Drug Removal by Hemoadsorption

open access: yesBlood Purification
Background: There is growing interest in hemoadsorption (HA) therapies in critically ill patients although their precise indications remain to be established. Several devices are available on the market with heterogeneous properties and capabilities. Summary: Due to the non-specific removal associated with most HA techniques, concerns have been raised
Ilona Lemagnen   +6 more
openaire   +3 more sources

Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass graftingCentral MessagePerspective

open access: yesJTCVS Open, 2023
Objectives: Patients on ticagrelor undergoing urgent cardiac surgery are at high risk for perioperative bleeding complications. We sought to determine whether intraoperative hemoadsorption could remove ticagrelor and lower circulating drug concentrations.
Kambiz Hassan, MD   +8 more
doaj   +2 more sources

Case Report: Adjunctive hemoadsorption therapy in a patient with Takotsubo cardiomyopathy and hyperinflammation [PDF]

open access: yesFrontiers in Medicine
IntroductionTakotsubo cardiomyopathy (TCM) is a transient, stress-related cardiac dysfunction that mimics acute coronary syndrome and is typically seen in postmenopausal women.
Jose O. Castro
doaj   +2 more sources

The Immunomodulatory Potential of Hemoadsorption in Burn Care

open access: yesBlood Purification
Burns are a common injury affecting thousands of people worldwide each year. Clinical severity varies according to the total body surface area burned, which is in turn associated with morbidity and mortality. The management of a severe burn patient requires admission to a referral center.
Nicolas Chardon   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy